End Price Gouging for Medications Act
USA117th CongressHR-2829| House
| Updated: 7/14/2021
Peter Welch
Democratic Representative
Vermont
Cosponsors (1)
Committees (10)
• Ways and Means Committee• Indian and Insular Affairs Subcommittee• Health Subcommittee• Health Subcommittee• Veterans' Affairs Committee• Health Subcommittee• Armed Services Committee• Energy and Commerce Committee• Oversight and Government Reform Committee• Natural Resources Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
End Price Gouging for Medications Act This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Subcommittee for Indigenous Peoples of the United States.
Referred to the Subcommittee on Health.
Health
AsiaAustraliaCanadaCivil actions and liabilityEuropeFranceGermanyHealth care costs and insuranceHealth care coverage and accessInflation and pricesItalyJapanMedicaidMedical researchMedicareMilitary medicineNetherlandsNorth AmericaOceaniaPrescription drugsRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care
End Price Gouging for Medications Act
USA117th CongressHR-2829| House
| Updated: 7/14/2021
End Price Gouging for Medications Act This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Subcommittee for Indigenous Peoples of the United States.
Referred to the Subcommittee on Health.
Peter Welch
Democratic Representative
Vermont
Cosponsors (1)
Committees (10)
• Ways and Means Committee• Indian and Insular Affairs Subcommittee• Health Subcommittee• Health Subcommittee• Veterans' Affairs Committee• Health Subcommittee• Armed Services Committee• Energy and Commerce Committee• Oversight and Government Reform Committee• Natural Resources Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
AsiaAustraliaCanadaCivil actions and liabilityEuropeFranceGermanyHealth care costs and insuranceHealth care coverage and accessInflation and pricesItalyJapanMedicaidMedical researchMedicareMilitary medicineNetherlandsNorth AmericaOceaniaPrescription drugsRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care